Clinical Trials Logo

Headache clinical trials

View clinical trials related to Headache.

Filter by:

NCT ID: NCT02473692 Withdrawn - Headache Clinical Trials

Facilitating Migraine Medication Adherence and Optimizing Medication Use

Start date: June 2017
Phase: N/A
Study type: Observational

The present research will pilot-test a new state-of-the-art Internet-based intervention targeting adherence facilitation and optimization of medication use, and will be evaluated to assess its utility in facilitating adherence and optimization of medication use for acute migraine pharmacotherapy. This is not an interventional study and will instead be an observational assessment of the feasibility of an online program (a proof-of-concept study). The two principal objectives of this study include: (a) examination of the feasibility and user usage patterns of an Internet-based intervention designed to potentially enhance adherence to medication use recommendations, and (b) determination of the efficacy of the Internet-based intervention in potentially increasing knowledge of abortive medication-use guidelines and in improving adherence to those guidelines. To meet the objectives of this study, a website has been specifically developed including a series of supplemental text-based headache materials and a series of videos based social learning theory and modeling principles (as opposed to the stereotypical 'talking-heads' mode of information delivery).

NCT ID: NCT02473276 Suspended - Clinical trials for Postdural Puncture Headache

2 Dose Neuraxial Morphine for Prevention of PDPH

Start date: September 2015
Phase: Phase 4
Study type: Interventional

Neuraxial analgesia (most commonly continuous epidural or combined spinal epidural) is the most effective modality available for pain relief during labor. Accidental dural puncture (ADP) with a large bore epidural needle and the resulting post-dural puncture headache (PDPH) is one of the most significant sources of anesthesia-related morbidity in parturients. Epidural blood patch (EBP) is the gold standard for treatment of PDPH, and although almost always effective, can result in another ADP, as well as low back pain and lower extremity pain. For this reason, effective measures to prevent PDPH when ADP occurs would be highly valuable. One small study in which 50 women were randomly allocated to receive 2 epidural injections of morphine or saline, demonstrated a beneficial effect of epidural morphine in decreasing the incidence of PDPH. This study aims to determine the efficacy of 2 doses of neuraxial (either epidural (EPID) or intrathecal) preservative-free morphine (PFM) to prevent headache after ADP in parturients.

NCT ID: NCT02472418 Completed - Migraine Clinical Trials

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Start date: June 5, 2015
Phase: Phase 2
Study type: Interventional

Crossover study of DFN-15 dose A versus DFN-15 dose B versus Placebo in the treatment of migraine headaches.

NCT ID: NCT02467127 Completed - Headache Clinical Trials

Vitamin D Plasma Level and Its Role in Headache

VITDHEAD
Start date: November 2015
Phase: N/A
Study type: Interventional

To date there are conflicting data concerning a correlation between plasma vitamin D levels and headache. The aim of this study was to evaluate plasma vitamin D levels in patients with headache admitted to the Center of Headache of Pugliese Ciaccio Hospital.

NCT ID: NCT02466334 Completed - Cluster Headache Clinical Trials

CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients

Start date: June 2015
Phase: N/A
Study type: Interventional

It has previously been shown that nitroglycerine induces cluster headache attacks in episodic cluster headache patients (ECH patients) in bouts but not in remission phase. Furthermore, plasma concentrations of calcitonin gene-related peptide (CGRP) have been shown to be significantly higher during, but not before and after, an attack. The attack appears around 20-40 min after nitroglycerine infusion with vasodilatation. During this latency period preceding the attack, no increase in CGRP plasma concentrations is seen. CGRP induces migraine attacks in 65% of migraine patients, and CGRP antagonists as well as monoclonal antibodies against CGRP are effective in migraine treatment. Based on the above the investigators hypothesize the following: 1. Provoking ECH patients in bout with CGRP triggers cluster headache attacks 2. Provoking ECH patients in remission with CGRP does not trigger cluster headache attacks 3. Provoking chronic cluster headache patients with CGRP triggers cluster headache attacks more often than in ECH patients.

NCT ID: NCT02462395 Completed - Clinical trials for Chronic Cluster Headache

Anodal Transcranial Direct Stimulation (tDCS) for the Treatment of Chronic Cluster Headache

ANODECCH
Start date: September 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Cluster headache is a primary headache that chiefly affects young men, and is less common than migraine. This disease can have devastating consequences due to the pain intensity (it is also called "suicide headache"), to the side effects of the drug preventive therapies, and to the resistance of some subtypes of the headache to all existing medications. Recent studies suggest that cluster headache could be associated with a decrease of the activity of frontal areas involved in descending pain control, in particular the subgenual anterior cingulate cortex. The aim of this pilot study is to activate these areas with a non-invasive neurostimulation technique, called transcranial direct current stimulation, as a preventive treatment for cluster headache sufferers.

NCT ID: NCT02460003 Enrolling by invitation - Cluster Headache Clinical Trials

Physiotherapy Program for Cluster Headache

PhyCH
Start date: April 2015
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness of physiotherapy program in the treatment of cluster headaches. Half of participants will receive a program of physiotherapy and usual drugs, while the other will receive an exercise program and usual drugs.

NCT ID: NCT02455323 Completed - Quality of Life Clinical Trials

The Influence of Manual Therapy in the Quality of Life in Tension-Type Headache

MTheadacheQL
Start date: March 2013
Phase: N/A
Study type: Interventional

The present study aims to assess the quality of life of patients suffering from tension-type headache (TTH) treated for 4 weeks with different manual therapy-based techniques. The study design involved a factorial, randomized, double-blind, controlled study

NCT ID: NCT02453399 Completed - Migraine Headache Clinical Trials

Relief of Migraine Pain Through Electro Stimulation

Start date: July 2015
Phase: N/A
Study type: Interventional

This study will evaluate transcutaneous electro stimulation device developed by Siano for adequacy, safety and efficacy for the treatment and/or prevention of migraine pain for migraine sufferers.

NCT ID: NCT02450955 Completed - Clinical trials for Tension-type Headache

Does the Addition of Manipulation Provide Added Benefit to Massage Therapy for Tension-type Headache Patients?

MANIHDI-II
Start date: February 2014
Phase: N/A
Study type: Interventional

Objective. To compare the benefits of spinal manipulation combined with massage therapy versus massage alone in patients with tension-type headache (TTH) on the frequency, intensity and disability caused by headache and on cervical range of motion. Method. A factorial, randomized, double-blinded, placebo-controlled clinical trial was conducted with a sample of 105 subjects diagnosed with TTH, divided into two groups: a) the treatment group received a manipulative technique followed by massage of the cervical and suboccipital region; a) the control group received massage alone. Four sessions (once per week) were applied over four weeks. The Headache Disability Inventory (HDI) was used to evaluate changes in the frequency and severity of headache and functional and emotional aspects of headache. Range of upper cervical and cervical flexion and extension were evaluated. Measures were conducted at baseline, immediately after the intervention (week 4) and at a follow up 8 weeks after completion of the intervention.